speb/financial-data huggingface dataset:
JNJ cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -1157000000.00
JNJ cash_flow (quarterly, 2025-09-30) — Net Short Term Debt Issuance: -4142000000.00
JNJ balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: -17508000000.00
JNJ balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Assets: 6666000000.00
JNJ balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 5988000000.00
JNJ balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Assets: 6666000000.00
JNJ balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 5988000000.00
JNJ income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 9278000000.00
JNJ income_statement (quarterly, 2025-09-30) — Normalized Income: 4989044708.39
JNJ cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 9169000000.00
JNJ cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: -57000000.00
JNJ income_statement (quarterly, 2025-09-30) — Operating Income: 7096000000.00
JNJ income_statement (quarterly, 2025-09-30) — Operating Revenue: 23993000000.00
JNJ balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 2406195000.00
JNJ balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 4292000000.00
JNJ balance_sheet (quarterly, 2025-09-30) — Other Equity Adjustments: -15237000000.00
JNJ income_statement (quarterly, 2025-09-30) — Other Gand A: 5922000000.00
JNJ income_statement (quarterly, 2025-09-30) — Other Income Expense: 437000000.00
JNJ balance_sheet (quarterly, 2025-09-30) — Other Intangible Assets: 48737000000.00
JNJ cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 17000000.00
JNJ balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 12416000000.00
JNJ balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 9926000000.00
JNJ income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 200000000.00
JNJ balance_sheet (quarterly, 2025-09-30) — Other Short Term Investments: 331000000.00
JNJ balance_sheet (quarterly, 2025-09-30) — Payables: 11553000000.00
JNJ balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 40510000000.00
JNJ balance_sheet (quarterly, 2025-09-30) — Pensionand Other Post Retirement Benefit Plans Current: 3972000000.00
JNJ income_statement (quarterly, 2025-09-30) — Pretax Income: 7493000000.00
JNJ cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 1274000000.00
JNJ cash_flow (quarterly, 2025-09-30) — Provisionand Write Offof Assets: -9000000.00
JNJ cash_flow (quarterly, 2025-09-30) — Purchase Of Business: -1000000.00
JNJ cash_flow (quarterly, 2025-09-30) — Purchase Of Intangibles: -16000000.00
JNJ cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: 100000000.00
JNJ cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -1157000000.00
JNJ balance_sheet (quarterly, 2025-09-30) — Raw Materials: 2552000000.00
JNJ balance_sheet (quarterly, 2025-09-30) — Receivables: 17611000000.00
JNJ income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 7303000000.00
JNJ income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 1777000000.00
JNJ cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -6467000000.00
JNJ cash_flow (quarterly, 2025-09-30) — Repurchase Of Capital Stock: -1902000000.00
JNJ income_statement (quarterly, 2025-09-30) — Research And Development: 3672000000.00
JNJ income_statement (quarterly, 2025-09-30) — Restructuring And Mergern Acquisition: 163000000.00
JNJ income_statement (quarterly, 2025-09-30) — Salaries And Wages: -100000000.00
JNJ cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 489000000.00
JNJ income_statement (quarterly, 2025-09-30) — Selling General And Administration: 5922000000.00
JNJ balance_sheet (quarterly, 2025-09-30) — Share Issued: 3119843000.00
JNJ cash_flow (quarterly, 2025-09-30) — Short Term Debt Issuance: 1324000000.00
JNJ cash_flow (quarterly, 2025-09-30) — Short Term Debt Payments: -5466000000.00
JNJ income_statement (quarterly, 2025-09-30) — Special Income Charges: -163000000.00
JNJ cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 347000000.00
JNJ balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 79277000000.00
JNJ balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: -17508000000.00
JNJ income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 74044708.39
JNJ income_statement (quarterly, 2025-09-30) — Tax Provision: 2341000000.00
JNJ income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.31
JNJ balance_sheet (quarterly, 2025-09-30) — Total Assets: 192816000000.00
JNJ balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 118685000000.00
JNJ balance_sheet (quarterly, 2025-09-30) — Total Debt: 45795000000.00
JNJ balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 79277000000.00
JNJ income_statement (quarterly, 2025-09-30) — Total Expenses: 16897000000.00
JNJ balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 113539000000.00
JNJ balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 138205000000.00
JNJ balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 62670000000.00
JNJ balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 1928000000.00
JNJ income_statement (quarterly, 2025-09-30) — Total Unusual Items: 237000000.00
JNJ income_statement (quarterly, 2025-09-30) — Total Unusual Items Excluding Goodwill: 237000000.00
JNJ balance_sheet (quarterly, 2025-09-30) — Tradeand Other Payables Non Current: 418000000.00
JNJ balance_sheet (quarterly, 2025-09-30) — Treasury Shares Number: 713648000.00
JNJ balance_sheet (quarterly, 2025-09-30) — Treasury Stock: 75887000000.00
JNJ balance_sheet (quarterly, 2025-09-30) — Work In Process: 3763000000.00
JNJ balance_sheet (quarterly, 2025-09-30) — Working Capital: 3742000000.00
JNJ income_statement (annual, 2025-12-31) — +Operating Expense: 38341000000.00
JNJ income_statement (quarterly, 2025-12-31) — +Operating Expense: 11005000000.00
JNJ income_statement (annual, 2025-12-31) — +Total Revenue: 94193000000.00
JNJ income_statement (quarterly, 2025-12-31) — +Total Revenue: 24564000000.00
JNJ balance_sheet (annual, 2025-12-31) — Accounts Payable: 11991000000.00
JNJ balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 11991000000.00
JNJ balance_sheet (annual, 2025-12-31) — Accounts Receivable: 17178000000.00
JNJ balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 17178000000.00
JNJ balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -31195000000.00
JNJ balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -31195000000.00
JNJ balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 168978000000.00
JNJ balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 168978000000.00
JNJ balance_sheet (annual, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -183000000.00
JNJ balance_sheet (quarterly, 2025-12-31) — Allowance For Doubtful Accounts Receivable: -183000000.00
JNJ cash_flow (annual, 2025-12-31) — Asset Impairment Charge: 204000000.00
JNJ cash_flow (quarterly, 2025-12-31) — Asset Impairment Charge: 81000000.00
JNJ income_statement (annual, 2025-12-31) — Basic Average Shares: 2407400000.00
JNJ income_statement (quarterly, 2025-12-31) — Basic Average Shares: 2407939000.00
JNJ income_statement (annual, 2025-12-31) — Basic EPS: 11.13
JNJ income_statement (quarterly, 2025-12-31) — Basic EPS: 2.12
JNJ cash_flow (annual, 2025-12-31) — Beginning Cash Position: 24105000000.00
JNJ cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 18231000000.00
JNJ balance_sheet (annual, 2025-12-31) — Buildings And Improvements: 13429000000.00
JNJ balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 13429000000.00
JNJ cash_flow (annual, 2025-12-31) — Capital Expenditure: -5217000000.00
JNJ cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -1837000000.00
JNJ balance_sheet (annual, 2025-12-31) — Capital Stock: 3120000000.00
JNJ balance_sheet (quarterly, 2025-12-31) — Capital Stock: 3120000000.00
JNJ balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 19709000000.00
JNJ balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 19709000000.00
JNJ balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 20102000000.00
JNJ balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 20102000000.00
JNJ cash_flow (annual, 2025-12-31) — Cash Dividends Paid: -12381000000.00
JNJ cash_flow (quarterly, 2025-12-31) — Cash Dividends Paid: -3131000000.00
JNJ balance_sheet (annual, 2025-12-31) — Cash Equivalents: 16410000000.00
JNJ balance_sheet (quarterly, 2025-12-31) — Cash Equivalents: 16410000000.00
JNJ balance_sheet (annual, 2025-12-31) — Cash Financial: 3299000000.00
JNJ balance_sheet (quarterly, 2025-12-31) — Cash Financial: 3299000000.00
JNJ cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -5539000000.00
JNJ cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -1369000000.00
JNJ cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -23588000000.00
JNJ cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -4485000000.00
JNJ cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 24530000000.00
JNJ cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 7309000000.00
JNJ cash_flow (annual, 2025-12-31) — Change In Inventory: -1450000000.00
JNJ cash_flow (quarterly, 2025-12-31) — Change In Inventory: -46000000.00
JNJ cash_flow (annual, 2025-12-31) — Change In Other Current Assets: -6167000000.00
JNJ cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: 1486000000.00
JNJ cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: -5697000000.00
JNJ cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: 499000000.00
JNJ cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 2377000000.00
JNJ cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 1266000000.00
JNJ cash_flow (annual, 2025-12-31) — Change In Receivables: -1781000000.00
JNJ cash_flow (quarterly, 2025-12-31) — Change In Receivables: 391000000.00
JNJ cash_flow (annual, 2025-12-31) — Change In Working Capital: -12718000000.00
JNJ cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 3596000000.00
JNJ cash_flow (annual, 2025-12-31) — Changes In Account Receivables: -1781000000.00
JNJ cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: 391000000.00
JNJ cash_flow (annual, 2025-12-31) — Changes In Cash: -4597000000.00
JNJ cash_flow (quarterly, 2025-12-31) — Changes In Cash: 1455000000.00
JNJ balance_sheet (annual, 2025-12-31) — Common Stock: 3120000000.00
JNJ balance_sheet (quarterly, 2025-12-31) — Common Stock: 3120000000.00
JNJ cash_flow (annual, 2025-12-31) — Common Stock Dividend Paid: -12381000000.00
JNJ cash_flow (quarterly, 2025-12-31) — Common Stock Dividend Paid: -3131000000.00
JNJ balance_sheet (annual, 2025-12-31) — Common Stock Equity: 81544000000.00
JNJ balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 81544000000.00
JNJ cash_flow (annual, 2025-12-31) — Common Stock Issuance: 0.00
JNJ cash_flow (annual, 2025-12-31) — Common Stock Payments: -5953000000.00
JNJ cash_flow (quarterly, 2025-12-31) — Common Stock Payments: -1924000000.00
JNJ balance_sheet (annual, 2025-12-31) — Construction In Progress: 7361000000.00
JNJ balance_sheet (quarterly, 2025-12-31) — Construction In Progress: 7361000000.00
JNJ income_statement (annual, 2025-12-31) — Cost Of Revenue: 30256000000.00
JNJ income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 7968000000.00
JNJ balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 27718000000.00
JNJ balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 27718000000.00
JNJ balance_sheet (annual, 2025-12-31) — Current Assets: 55624000000.00
JNJ balance_sheet (quarterly, 2025-12-31) — Current Assets: 55624000000.00
JNJ balance_sheet (annual, 2025-12-31) — Current Debt: 8495000000.00
JNJ balance_sheet (quarterly, 2025-12-31) — Current Debt: 8495000000.00
JNJ balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 8495000000.00
JNJ balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 8495000000.00
JNJ balance_sheet (annual, 2025-12-31) — Current Liabilities: 54126000000.00
JNJ balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 54126000000.00
JNJ cash_flow (annual, 2025-12-31) — Deferred Income Tax: 1538000000.00
JNJ cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: -3677000000.00
JNJ cash_flow (annual, 2025-12-31) — Deferred Tax: 1538000000.00
JNJ cash_flow (quarterly, 2025-12-31) — Deferred Tax: -3677000000.00
JNJ cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 7503000000.00
JNJ cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 2011000000.00
JNJ cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 7503000000.00
JNJ cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 2011000000.00
JNJ income_statement (annual, 2025-12-31) — Diluted Average Shares: 2429400000.00
JNJ income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 2439000000.00
JNJ income_statement (annual, 2025-12-31) — Diluted EPS: 11.03
JNJ income_statement (quarterly, 2025-12-31) — Diluted EPS: 2.10
JNJ income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 26804000000.00
JNJ income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 5116000000.00
JNJ income_statement (annual, 2025-12-31) — EBIT: 33552000000.00
JNJ income_statement (quarterly, 2025-12-31) — EBIT: 5180000000.00
JNJ income_statement (annual, 2025-12-31) — EBITDA: 41055000000.00
JNJ income_statement (quarterly, 2025-12-31) — EBITDA: 7191000000.00
JNJ cash_flow (annual, 2025-12-31) — Effect Of Exchange Rate Changes: 201000000.00
JNJ cash_flow (quarterly, 2025-12-31) — Effect Of Exchange Rate Changes: 23000000.00
JNJ balance_sheet (annual, 2025-12-31) — Employee Benefits: 6957000000.00
JNJ balance_sheet (quarterly, 2025-12-31) — Employee Benefits: 6957000000.00
JNJ cash_flow (annual, 2025-12-31) — End Cash Position: 19709000000.00
JNJ cash_flow (quarterly, 2025-12-31) — End Cash Position: 19709000000.00
JNJ cash_flow (annual, 2025-12-31) — Financing Cash Flow: -5539000000.00
JNJ cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -1369000000.00
JNJ balance_sheet (annual, 2025-12-31) — Finished Goods: 7833000000.00
JNJ balance_sheet (quarterly, 2025-12-31) — Finished Goods: 7833000000.00
JNJ cash_flow (annual, 2025-12-31) — Free Cash Flow: 19313000000.00
JNJ cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 5472000000.00
JNJ cash_flow (annual, 2025-12-31) — Gain Loss On Sale Of Business: -263000000.00
JNJ income_statement (annual, 2025-12-31) — Gain On Sale Of Security: 400000000.00
JNJ income_statement (quarterly, 2025-12-31) — Gain On Sale Of Security: 100000000.00
JNJ balance_sheet (annual, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -14930000000.00
JNJ balance_sheet (quarterly, 2025-12-31) — Gains Losses Not Affecting Retained Earnings: -14930000000.00
JNJ balance_sheet (annual, 2025-12-31) — Goodwill: 48772000000.00
JNJ balance_sheet (quarterly, 2025-12-31) — Goodwill: 48772000000.00
JNJ balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 99175000000.00
JNJ balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 99175000000.00
JNJ balance_sheet (annual, 2025-12-31) — Gross Accounts Receivable: 17361000000.00
JNJ balance_sheet (quarterly, 2025-12-31) — Gross Accounts Receivable: 17361000000.00
JNJ balance_sheet (annual, 2025-12-31) — Gross PPE: 54364000000.00
JNJ balance_sheet (quarterly, 2025-12-31) — Gross PPE: 54364000000.00
JNJ income_statement (annual, 2025-12-31) — Gross Profit: 63937000000.00
JNJ income_statement (quarterly, 2025-12-31) — Gross Profit: 16596000000.00
JNJ income_statement (annual, 2025-12-31) — Impairment Of Capital Assets: 81000000.00
JNJ cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 6539000000.00
JNJ balance_sheet (annual, 2025-12-31) — Income Tax Payable: 1388000000.00
JNJ balance_sheet (quarterly, 2025-12-31) — Income Tax Payable: 1388000000.00
JNJ income_statement (annual, 2025-12-31) — Interest Expense: 971000000.00
JNJ income_statement (quarterly, 2025-12-31) — Interest Expense: 214000000.00
JNJ income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 971000000.00
JNJ income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 214000000.00
JNJ income_statement (annual, 2025-12-31) — Interest Income: 1056000000.00
JNJ income_statement (quarterly, 2025-12-31) — Interest Income: 237000000.00
JNJ income_statement (annual, 2025-12-31) — Interest Income Non Operating: 1056000000.00
JNJ income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 237000000.00
JNJ cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 1977000000.00
JNJ balance_sheet (annual, 2025-12-31) — Inventory: 14191000000.00
JNJ balance_sheet (quarterly, 2025-12-31) — Inventory: 14191000000.00
JNJ balance_sheet (annual, 2025-12-31) — Invested Capital: 129477000000.00
JNJ balance_sheet (quarterly, 2025-12-31) — Invested Capital: 129477000000.00
JNJ cash_flow (annual, 2025-12-31) — Investing Cash Flow: -23588000000.00
JNJ cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -4485000000.00
JNJ cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 0.00
JNJ cash_flow (annual, 2025-12-31) — Issuance Of Debt: 23724000000.00
JNJ cash_flow (quarterly, 2025-12-31) — Issuance Of Debt: 3913000000.00
JNJ balance_sheet (annual, 2025-12-31) — Land And Improvements: 701000000.00
JNJ balance_sheet (quarterly, 2025-12-31) — Land And Improvements: 701000000.00
JNJ balance_sheet (annual, 2025-12-31) — Long Term Debt: 39438000000.00
JNJ balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 39438000000.00
JNJ balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 39438000000.00
JNJ balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 39438000000.00
JNJ cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 9138000000.00
JNJ cash_flow (quarterly, 2025-12-31) — Long Term Debt Issuance: 0.00
JNJ cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -1757000000.00
JNJ cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -2000000.00
JNJ balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 32873000000.00
JNJ balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 32873000000.00
JNJ cash_flow (annual, 2025-12-31) — Net Business Purchase And Sale: -17541000000.00
JNJ cash_flow (quarterly, 2025-12-31) — Net Business Purchase And Sale: -3082000000.00
JNJ cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: -5953000000.00
JNJ cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: -1924000000.00
JNJ balance_sheet (annual, 2025-12-31) — Net Debt: 28224000000.00
JNJ balance_sheet (quarterly, 2025-12-31) — Net Debt: 28224000000.00
JNJ income_statement (annual, 2025-12-31) — Net Income: 26804000000.00
JNJ income_statement (quarterly, 2025-12-31) — Net Income: 5116000000.00
JNJ income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 26804000000.00
JNJ income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 5116000000.00
JNJ income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 26804000000.00
JNJ income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 5116000000.00
JNJ income_statement (annual, 2025-12-31) — Net Income Discontinuous Operations: 0.00
JNJ income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 26804000000.00
JNJ income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 5116000000.00
JNJ income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 26804000000.00
JNJ income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 5116000000.00
JNJ cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 26804000000.00
JNJ cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 5116000000.00
JNJ income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 26804000000.00
JNJ income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 5116000000.00
JNJ cash_flow (annual, 2025-12-31) — Net Intangibles Purchase And Sale: -385000000.00
JNJ cash_flow (quarterly, 2025-12-31) — Net Intangibles Purchase And Sale: 0.00
JNJ income_statement (annual, 2025-12-31) — Net Interest Income: 85000000.00
JNJ income_statement (quarterly, 2025-12-31) — Net Interest Income: 23000000.00
JNJ cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: 741000000.00
JNJ cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: 2314000000.00
JNJ cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: 9637000000.00
JNJ cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: 2105000000.00
JNJ cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: 7381000000.00
JNJ cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -2000000.00
JNJ income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: 85000000.00
JNJ income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: 23000000.00
JNJ cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -260000000.00
JNJ cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: -6000000.00
JNJ cash_flow (annual, 2025-12-31) — Net Other Investing Changes: -1571000000.00
JNJ cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: -1880000000.00
JNJ balance_sheet (annual, 2025-12-31) — Net PPE: 23169000000.00
JNJ balance_sheet (quarterly, 2025-12-31) — Net PPE: 23169000000.00
JNJ cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -4832000000.00
JNJ cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -1837000000.00
JNJ cash_flow (annual, 2025-12-31) — Net Short Term Debt Issuance: 2256000000.00
JNJ cash_flow (quarterly, 2025-12-31) — Net Short Term Debt Issuance: 2107000000.00
JNJ balance_sheet (annual, 2025-12-31) — Net Tangible Assets: -17631000000.00
JNJ balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: -17631000000.00
JNJ balance_sheet (annual, 2025-12-31) — Non Current Deferred Assets: 6874000000.00
JNJ balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Assets: 6874000000.00
JNJ balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 6791000000.00
JNJ balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 6791000000.00
JNJ balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Assets: 6874000000.00
JNJ balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Assets: 6874000000.00
JNJ balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 6791000000.00
JNJ balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 6791000000.00
JNJ income_statement (annual, 2025-12-31) — Normalized EBITDA: 35164000000.00
JNJ income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 7956000000.00
JNJ income_statement (annual, 2025-12-31) — Normalized Income: 21957544581.20
JNJ income_statement (quarterly, 2025-12-31) — Normalized Income: 5720350000.00
JNJ cash_flow (annual, 2025-12-31) — Operating Cash Flow: 24530000000.00
JNJ cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 7309000000.00
JNJ cash_flow (annual, 2025-12-31) — Operating Gains Losses: -263000000.00
JNJ cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: -132000000.00
JNJ income_statement (annual, 2025-12-31) — Operating Income: 25596000000.00
JNJ income_statement (quarterly, 2025-12-31) — Operating Income: 5591000000.00
JNJ income_statement (annual, 2025-12-31) — Operating Revenue: 94193000000.00
JNJ income_statement (quarterly, 2025-12-31) — Operating Revenue: 24564000000.00
JNJ balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 2407939000.00
JNJ balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 2407939000.00
JNJ balance_sheet (annual, 2025-12-31) — Other Current Borrowings: 8495000000.00
JNJ balance_sheet (quarterly, 2025-12-31) — Other Current Borrowings: 8495000000.00
JNJ balance_sheet (annual, 2025-12-31) — Other Equity Adjustments: -14930000000.00
JNJ balance_sheet (quarterly, 2025-12-31) — Other Equity Adjustments: -14930000000.00
JNJ income_statement (annual, 2025-12-31) — Other Income Expense: 6891000000.00
JNJ income_statement (quarterly, 2025-12-31) — Other Income Expense: -665000000.00
JNJ balance_sheet (annual, 2025-12-31) — Other Intangible Assets: 50403000000.00
JNJ balance_sheet (quarterly, 2025-12-31) — Other Intangible Assets: 50403000000.00
JNJ cash_flow (annual, 2025-12-31) — Other Non Cash Items: 109000000.00
JNJ cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 0.00
JNJ balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 14368000000.00
JNJ balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 14368000000.00
JNJ balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 9868000000.00
JNJ balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 9868000000.00
JNJ income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: 1000000000.00
JNJ income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 100000000.00
JNJ balance_sheet (annual, 2025-12-31) — Other Receivables: 4153000000.00
JNJ balance_sheet (quarterly, 2025-12-31) — Other Receivables: 4153000000.00
JNJ balance_sheet (annual, 2025-12-31) — Other Short Term Investments: 393000000.00
JNJ balance_sheet (quarterly, 2025-12-31) — Other Short Term Investments: 393000000.00
JNJ income_statement (annual, 2025-12-31) — Other Special Charges: -6000000000.00
JNJ income_statement (quarterly, 2025-12-31) — Other Special Charges: 900000000.00
JNJ balance_sheet (annual, 2025-12-31) — Payables: 13379000000.00
JNJ balance_sheet (quarterly, 2025-12-31) — Payables: 13379000000.00
JNJ balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 41097000000.00
JNJ balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 41097000000.00
JNJ balance_sheet (annual, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 4534000000.00
JNJ balance_sheet (quarterly, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 4534000000.00
JNJ balance_sheet (annual, 2025-12-31) — Preferred Stock: 0.00
JNJ balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 0.00
JNJ income_statement (annual, 2025-12-31) — Pretax Income: 32581000000.00
JNJ income_statement (quarterly, 2025-12-31) — Pretax Income: 4966000000.00
JNJ cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 3418000000.00
JNJ cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 1587000000.00
JNJ balance_sheet (annual, 2025-12-31) — Properties: 0.00
JNJ balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
JNJ cash_flow (annual, 2025-12-31) — Provisionand Write Offof Assets: -1000000.00
JNJ cash_flow (quarterly, 2025-12-31) — Provisionand Write Offof Assets: 5000000.00
JNJ cash_flow (annual, 2025-12-31) — Purchase Of Business: -17541000000.00
JNJ cash_flow (quarterly, 2025-12-31) — Purchase Of Business: -3082000000.00
JNJ cash_flow (annual, 2025-12-31) — Purchase Of Intangibles: -385000000.00
JNJ cash_flow (quarterly, 2025-12-31) — Purchase Of Intangibles: 0.00
JNJ cash_flow (annual, 2025-12-31) — Purchase Of Investment: -920000000.00
JNJ cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: 2095000000.00
JNJ cash_flow (annual, 2025-12-31) — Purchase Of PPE: -4832000000.00
JNJ cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -1837000000.00
JNJ balance_sheet (annual, 2025-12-31) — Raw Materials: 2530000000.00
JNJ balance_sheet (quarterly, 2025-12-31) — Raw Materials: 2530000000.00
JNJ balance_sheet (annual, 2025-12-31) — Receivables: 21331000000.00
JNJ balance_sheet (quarterly, 2025-12-31) — Receivables: 21331000000.00
JNJ income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 30256000000.00
JNJ income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 7968000000.00
JNJ income_statement (annual, 2025-12-31) — Reconciled Depreciation: 7503000000.00
JNJ income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 2011000000.00
JNJ cash_flow (annual, 2025-12-31) — Repayment Of Debt: -14087000000.00
JNJ cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -1808000000.00
JNJ cash_flow (annual, 2025-12-31) — Repurchase Of Capital Stock: -5953000000.00
JNJ cash_flow (quarterly, 2025-12-31) — Repurchase Of Capital Stock: -1924000000.00
JNJ income_statement (annual, 2025-12-31) — Research And Development: 14665000000.00
JNJ income_statement (quarterly, 2025-12-31) — Research And Development: 4252000000.00
JNJ income_statement (annual, 2025-12-31) — Restructuring And Mergern Acquisition: 428000000.00
JNJ income_statement (quarterly, 2025-12-31) — Restructuring And Mergern Acquisition: -116000000.00
JNJ cash_flow (annual, 2025-12-31) — Sale Of Investment: 1661000000.00
JNJ cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 219000000.00
JNJ income_statement (annual, 2025-12-31) — Selling General And Administration: 23676000000.00
JNJ income_statement (quarterly, 2025-12-31) — Selling General And Administration: 6753000000.00
JNJ balance_sheet (annual, 2025-12-31) — Share Issued: 3119843000.00
JNJ balance_sheet (quarterly, 2025-12-31) — Share Issued: 3119843000.00
JNJ cash_flow (annual, 2025-12-31) — Short Term Debt Issuance: 14586000000.00
JNJ cash_flow (quarterly, 2025-12-31) — Short Term Debt Issuance: 3913000000.00
JNJ cash_flow (annual, 2025-12-31) — Short Term Debt Payments: -12330000000.00
JNJ cash_flow (quarterly, 2025-12-31) — Short Term Debt Payments: -1806000000.00
JNJ income_statement (annual, 2025-12-31) — Special Income Charges: 5491000000.00
JNJ income_statement (quarterly, 2025-12-31) — Special Income Charges: -865000000.00
JNJ cash_flow (annual, 2025-12-31) — Stock Based Compensation: 1354000000.00
JNJ cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 309000000.00
JNJ balance_sheet (annual, 2025-12-31) — Stockholders Equity: 81544000000.00
JNJ balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 81544000000.00
JNJ balance_sheet (annual, 2025-12-31) — Tangible Book Value: -17631000000.00
JNJ balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: -17631000000.00
JNJ income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 1044544581.20
JNJ income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: -160650000.00
JNJ income_statement (annual, 2025-12-31) — Tax Provision: 5777000000.00
JNJ income_statement (quarterly, 2025-12-31) — Tax Provision: -150000000.00
JNJ income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.18
JNJ income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.21
JNJ balance_sheet (annual, 2025-12-31) — Total Assets: 199210000000.00
JNJ balance_sheet (quarterly, 2025-12-31) — Total Assets: 199210000000.00
JNJ balance_sheet (annual, 2025-12-31) — Total Capitalization: 120982000000.00
JNJ balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 120982000000.00
JNJ balance_sheet (annual, 2025-12-31) — Total Debt: 47933000000.00
JNJ balance_sheet (quarterly, 2025-12-31) — Total Debt: 47933000000.00
JNJ balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 81544000000.00
JNJ balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 81544000000.00
JNJ income_statement (annual, 2025-12-31) — Total Expenses: 68597000000.00
JNJ income_statement (quarterly, 2025-12-31) — Total Expenses: 18973000000.00
JNJ balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 117666000000.00
JNJ balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 117666000000.00
JNJ balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 143586000000.00
JNJ balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 143586000000.00
JNJ balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 63540000000.00
JNJ balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 63540000000.00
JNJ balance_sheet (annual, 2025-12-31) — Total Tax Payable: 1388000000.00
JNJ balance_sheet (quarterly, 2025-12-31) — Total Tax Payable: 1388000000.00
JNJ income_statement (annual, 2025-12-31) — Total Unusual Items: 5891000000.00
JNJ income_statement (quarterly, 2025-12-31) — Total Unusual Items: -765000000.00
JNJ income_statement (annual, 2025-12-31) — Total Unusual Items Excluding Goodwill: 5891000000.00
JNJ income_statement (quarterly, 2025-12-31) — Total Unusual Items Excluding Goodwill: -765000000.00
JNJ balance_sheet (annual, 2025-12-31) — Tradeand Other Payables Non Current: 486000000.00
JNJ balance_sheet (quarterly, 2025-12-31) — Tradeand Other Payables Non Current: 486000000.00
JNJ balance_sheet (annual, 2025-12-31) — Treasury Shares Number: 711904000.00
JNJ balance_sheet (quarterly, 2025-12-31) — Treasury Shares Number: 711904000.00
JNJ balance_sheet (annual, 2025-12-31) — Treasury Stock: 75624000000.00
JNJ balance_sheet (quarterly, 2025-12-31) — Treasury Stock: 75624000000.00
JNJ balance_sheet (annual, 2025-12-31) — Work In Process: 3828000000.00
JNJ balance_sheet (quarterly, 2025-12-31) — Work In Process: 3828000000.00
JNJ balance_sheet (annual, 2025-12-31) — Working Capital: 1498000000.00
JNJ balance_sheet (quarterly, 2025-12-31) — Working Capital: 1498000000.00
JNJ income_statement (quarterly, 2026-03-31) — +Operating Expense: 9561000000.00
JNJ income_statement (quarterly, 2026-03-31) — +Total Revenue: 24062000000.00
JNJ balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 10460000000.00
JNJ balance_sheet (quarterly, 2026-03-31) — Accounts Receivable: 17721000000.00
JNJ balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -31425000000.00
JNJ balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 169161000000.00
JNJ balance_sheet (quarterly, 2026-03-31) — Allowance For Doubtful Accounts Receivable: -174000000.00
JNJ cash_flow (quarterly, 2026-03-31) — Asset Impairment Charge: 36000000.00
JNJ income_statement (quarterly, 2026-03-31) — Basic Average Shares: 2408700000.00
JNJ income_statement (quarterly, 2026-03-31) — Basic EPS: 2.17
JNJ cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 19709000000.00
JNJ cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -1049000000.00
JNJ balance_sheet (quarterly, 2026-03-31) — Capital Stock: 3120000000.00
JNJ balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 21688000000.00
JNJ balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 22051000000.00
JNJ cash_flow (quarterly, 2026-03-31) — Cash Dividends Paid: -3131000000.00
JNJ balance_sheet (quarterly, 2026-03-31) — Cash Equivalents: 18378000000.00
JNJ balance_sheet (quarterly, 2026-03-31) — Cash Financial: 3310000000.00
JNJ cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 530000000.00
JNJ cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -1040000000.00
JNJ cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: 2514000000.00
JNJ cash_flow (quarterly, 2026-03-31) — Change In Inventory: -431000000.00
JNJ cash_flow (quarterly, 2026-03-31) — Change In Other Current Assets: 349000000.00
JNJ cash_flow (quarterly, 2026-03-31) — Change In Other Current Liabilities: -629000000.00
JNJ cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -3920000000.00
JNJ cash_flow (quarterly, 2026-03-31) — Change In Receivables: -595000000.00
JNJ cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -5226000000.00
JNJ cash_flow (quarterly, 2026-03-31) — Changes In Account Receivables: -595000000.00
JNJ cash_flow (quarterly, 2026-03-31) — Changes In Cash: 2004000000.00
JNJ balance_sheet (quarterly, 2026-03-31) — Common Stock: 3120000000.00
JNJ cash_flow (quarterly, 2026-03-31) — Common Stock Dividend Paid: -3131000000.00
JNJ balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 81186000000.00
JNJ cash_flow (quarterly, 2026-03-31) — Common Stock Payments: -4028000000.00
JNJ income_statement (quarterly, 2026-03-31) — Cost Of Revenue: 8106000000.00
JNJ balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 25798000000.00
JNJ balance_sheet (quarterly, 2026-03-31) — Current Assets: 59173000000.00
JNJ balance_sheet (quarterly, 2026-03-31) — Current Debt: 17460000000.00
JNJ balance_sheet (quarterly, 2026-03-31) — Current Debt And Capital Lease Obligation: 17460000000.00
JNJ balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 57716000000.00
JNJ cash_flow (quarterly, 2026-03-31) — Deferred Income Tax: 159000000.00
JNJ cash_flow (quarterly, 2026-03-31) — Deferred Tax: 159000000.00
JNJ cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 2004000000.00
JNJ cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 2004000000.00
JNJ income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 2445200000.00
JNJ income_statement (quarterly, 2026-03-31) — Diluted EPS: 2.14
JNJ income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: 5235000000.00
JNJ income_statement (quarterly, 2026-03-31) — EBIT: 6262000000.00
JNJ income_statement (quarterly, 2026-03-31) — EBITDA: 8266000000.00
JNJ cash_flow (quarterly, 2026-03-31) — Effect Of Exchange Rate Changes: -25000000.00
JNJ balance_sheet (quarterly, 2026-03-31) — Employee Benefits: 6760000000.00
JNJ cash_flow (quarterly, 2026-03-31) — End Cash Position: 21688000000.00
JNJ cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 530000000.00
JNJ balance_sheet (quarterly, 2026-03-31) — Finished Goods: 7938000000.00
JNJ cash_flow (quarterly, 2026-03-31) — Free Cash Flow: 1465000000.00
JNJ balance_sheet (quarterly, 2026-03-31) — Gains Losses Not Affecting Retained Earnings: -14831000000.00
JNJ balance_sheet (quarterly, 2026-03-31) — Goodwill: 48558000000.00
JNJ balance_sheet (quarterly, 2026-03-31) — Goodwill And Other Intangible Assets: 97619000000.00
JNJ balance_sheet (quarterly, 2026-03-31) — Gross Accounts Receivable: 17895000000.00
JNJ balance_sheet (quarterly, 2026-03-31) — Gross PPE: 54695000000.00
JNJ income_statement (quarterly, 2026-03-31) — Gross Profit: 15956000000.00
JNJ balance_sheet (quarterly, 2026-03-31) — Income Tax Payable: 1087000000.00
JNJ income_statement (quarterly, 2026-03-31) — Interest Expense: 272000000.00
JNJ income_statement (quarterly, 2026-03-31) — Interest Expense Non Operating: 272000000.00
JNJ income_statement (quarterly, 2026-03-31) — Interest Income: 229000000.00
JNJ income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 229000000.00
JNJ balance_sheet (quarterly, 2026-03-31) — Inventory: 14583000000.00
JNJ balance_sheet (quarterly, 2026-03-31) — Invested Capital: 136173000000.00
JNJ cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -1040000000.00
JNJ cash_flow (quarterly, 2026-03-31) — Issuance Of Debt: 12439000000.00
JNJ balance_sheet (quarterly, 2026-03-31) — Long Term Debt: 37527000000.00
JNJ balance_sheet (quarterly, 2026-03-31) — Long Term Debt And Capital Lease Obligation: 37527000000.00
JNJ cash_flow (quarterly, 2026-03-31) — Long Term Debt Issuance: 0.00
JNJ cash_flow (quarterly, 2026-03-31) — Long Term Debt Payments: -2002000000.00
JNJ cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: -4028000000.00
JNJ balance_sheet (quarterly, 2026-03-31) — Net Debt: 33299000000.00
JNJ income_statement (quarterly, 2026-03-31) — Net Income: 5235000000.00
JNJ income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: 5235000000.00
JNJ income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: 5235000000.00
JNJ income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: 5235000000.00
JNJ income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: 5235000000.00
JNJ cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: 5235000000.00
JNJ income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: 5235000000.00
JNJ cash_flow (quarterly, 2026-03-31) — Net Intangibles Purchase And Sale: 0.00
JNJ income_statement (quarterly, 2026-03-31) — Net Interest Income: -43000000.00
JNJ cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: 65000000.00
JNJ cash_flow (quarterly, 2026-03-31) — Net Issuance Payments Of Debt: 7214000000.00
JNJ cash_flow (quarterly, 2026-03-31) — Net Long Term Debt Issuance: -2002000000.00
JNJ income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: -43000000.00
JNJ cash_flow (quarterly, 2026-03-31) — Net Other Financing Charges: -697000000.00
JNJ cash_flow (quarterly, 2026-03-31) — Net Other Investing Changes: -56000000.00
JNJ balance_sheet (quarterly, 2026-03-31) — Net PPE: 23270000000.00
JNJ cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -1049000000.00
JNJ cash_flow (quarterly, 2026-03-31) — Net Short Term Debt Issuance: 9216000000.00
JNJ balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: -16433000000.00
JNJ balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Assets: 6727000000.00
JNJ balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Liabilities: 7011000000.00
JNJ balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Assets: 6727000000.00
JNJ balance_sheet (quarterly, 2026-03-31) — Non Current Deferred Taxes Liabilities: 7011000000.00
JNJ income_statement (quarterly, 2026-03-31) — Normalized EBITDA: 8734000000.00
JNJ income_statement (quarterly, 2026-03-31) — Normalized Income: 5644011686.14
JNJ cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: 2514000000.00
JNJ cash_flow (quarterly, 2026-03-31) — Operating Gains Losses: 12000000.00
JNJ income_statement (quarterly, 2026-03-31) — Operating Income: 6395000000.00
JNJ income_statement (quarterly, 2026-03-31) — Operating Revenue: 24062000000.00
JNJ balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 2406585000.00
JNJ balance_sheet (quarterly, 2026-03-31) — Other Equity Adjustments: -14831000000.00
JNJ income_statement (quarterly, 2026-03-31) — Other Income Expense: -362000000.00
JNJ balance_sheet (quarterly, 2026-03-31) — Other Intangible Assets: 49061000000.00
JNJ cash_flow (quarterly, 2026-03-31) — Other Non Cash Items: 2000000.00
JNJ balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 14105000000.00
JNJ balance_sheet (quarterly, 2026-03-31) — Other Non Current Liabilities: 10208000000.00
JNJ income_statement (quarterly, 2026-03-31) — Other Non Operating Income Expenses: 106000000.00
JNJ balance_sheet (quarterly, 2026-03-31) — Other Receivables: 4818000000.00
JNJ balance_sheet (quarterly, 2026-03-31) — Other Short Term Investments: 363000000.00
JNJ income_statement (quarterly, 2026-03-31) — Other Special Charges: 300000000.00
JNJ balance_sheet (quarterly, 2026-03-31) — Payables: 11547000000.00
JNJ balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 37345000000.00
JNJ balance_sheet (quarterly, 2026-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 2911000000.00
JNJ income_statement (quarterly, 2026-03-31) — Pretax Income: 5990000000.00
JNJ cash_flow (quarterly, 2026-03-31) — Proceeds From Stock Option Exercised: 1172000000.00
JNJ cash_flow (quarterly, 2026-03-31) — Provisionand Write Offof Assets: -8000000.00
JNJ cash_flow (quarterly, 2026-03-31) — Purchase Of Intangibles: 0.00
JNJ cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: -144000000.00
JNJ cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -1049000000.00
JNJ balance_sheet (quarterly, 2026-03-31) — Raw Materials: 2612000000.00
JNJ balance_sheet (quarterly, 2026-03-31) — Receivables: 22539000000.00
JNJ income_statement (quarterly, 2026-03-31) — Reconciled Cost Of Revenue: 8106000000.00
JNJ income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 2004000000.00
JNJ cash_flow (quarterly, 2026-03-31) — Repayment Of Debt: -5225000000.00
JNJ cash_flow (quarterly, 2026-03-31) — Repurchase Of Capital Stock: -4028000000.00
JNJ income_statement (quarterly, 2026-03-31) — Research And Development: 3527000000.00
JNJ income_statement (quarterly, 2026-03-31) — Restructuring And Mergern Acquisition: 132000000.00
JNJ cash_flow (quarterly, 2026-03-31) — Sale Of Investment: 209000000.00
JNJ income_statement (quarterly, 2026-03-31) — Selling General And Administration: 6034000000.00
JNJ balance_sheet (quarterly, 2026-03-31) — Share Issued: 3119843000.00
JNJ cash_flow (quarterly, 2026-03-31) — Short Term Debt Issuance: 12439000000.00
JNJ cash_flow (quarterly, 2026-03-31) — Short Term Debt Payments: -3223000000.00
JNJ income_statement (quarterly, 2026-03-31) — Special Income Charges: -468000000.00
JNJ cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 300000000.00
JNJ balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 81186000000.00
JNJ balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: -16433000000.00
JNJ income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: -58988313.86
JNJ income_statement (quarterly, 2026-03-31) — Tax Provision: 755000000.00
JNJ income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.13
JNJ balance_sheet (quarterly, 2026-03-31) — Total Assets: 200894000000.00
JNJ balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 118713000000.00
JNJ balance_sheet (quarterly, 2026-03-31) — Total Debt: 54987000000.00
JNJ balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 81186000000.00
JNJ income_statement (quarterly, 2026-03-31) — Total Expenses: 17667000000.00
JNJ balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 119708000000.00
JNJ balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 141721000000.00
JNJ balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 61992000000.00
JNJ balance_sheet (quarterly, 2026-03-31) — Total Tax Payable: 1087000000.00
JNJ income_statement (quarterly, 2026-03-31) — Total Unusual Items: -468000000.00
JNJ income_statement (quarterly, 2026-03-31) — Total Unusual Items Excluding Goodwill: -468000000.00
JNJ balance_sheet (quarterly, 2026-03-31) — Tradeand Other Payables Non Current: 486000000.00
JNJ balance_sheet (quarterly, 2026-03-31) — Treasury Shares Number: 713258000.00
JNJ balance_sheet (quarterly, 2026-03-31) — Treasury Stock: 76264000000.00
JNJ balance_sheet (quarterly, 2026-03-31) — Work In Process: 4033000000.00
JNJ balance_sheet (quarterly, 2026-03-31) — Working Capital: 1457000000.00
JNJ income_statement (quarterly, 2026-03-31) — Write Off: 36000000.00
JNJ income_statement (quarterly, 2026-06-30) — +Operating Expense: 10085000000.00
JNJ income_statement (quarterly, 2026-06-30) — +Total Revenue: 25310000000.00
JNJ balance_sheet (quarterly, 2026-06-30) — Accounts Payable: 9223000000.00
JNJ balance_sheet (quarterly, 2026-06-30) — Accounts Receivable: 19046000000.00
JNJ balance_sheet (quarterly, 2026-06-30) — Accumulated Depreciation: -31936000000.00
JNJ balance_sheet (quarterly, 2026-06-30) — Additional Paid In Capital: 171665000000.00
JNJ balance_sheet (quarterly, 2026-06-30) — Allowance For Doubtful Accounts Receivable: -171000000.00
JNJ cash_flow (quarterly, 2026-06-30) — Asset Impairment Charge: 184000000.00
JNJ income_statement (quarterly, 2026-06-30) — Basic Average Shares: 2408228000.00
JNJ income_statement (quarterly, 2026-06-30) — Basic EPS: 2.30
JNJ cash_flow (quarterly, 2026-06-30) — Beginning Cash Position: 21688000000.00
JNJ cash_flow (quarterly, 2026-06-30) — Capital Expenditure: -1321000000.00
JNJ balance_sheet (quarterly, 2026-06-30) — Capital Stock: 3120000000.00
JNJ balance_sheet (quarterly, 2026-06-30) — Cash And Cash Equivalents: 20422000000.00
JNJ balance_sheet (quarterly, 2026-06-30) — Cash Cash Equivalents And Short Term Investments: 20758000000.00
JNJ cash_flow (quarterly, 2026-06-30) — Cash Dividends Paid: -3227000000.00
JNJ balance_sheet (quarterly, 2026-06-30) — Cash Equivalents: 17187000000.00
JNJ balance_sheet (quarterly, 2026-06-30) — Cash Financial: 3235000000.00